TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of active workers in employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Durable Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity practice
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Follicular damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first appearance of non-consistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reasons for failure to appear for scheduled injection visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: recommended prescribing of analgetics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: IL-1beta levels in tracheal aspirate material
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-6 level in tracheal aspirate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: oxygen saturation variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: cardiac output with ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glottis View (C&L Grade)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of changes in care management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration needed to arrest vitiligo activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of maintaining vitiligo stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life questionnaire (Prom)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Net promoter score questionnaire (NPS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effects to health and social services use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Analgesic effects measured by Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic effects measured by Revised American Pain Society Patient Outcome Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 2 Minute Walk Test (2MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access to maternal health care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete Resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactogenicity of MSP3
Endpoint domain: Adverse events/effects
Primary endpoint: Specificity of PoC HIV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity of PoC HIV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: overall survival in 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Bispectral Index (BIS) maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional disability inventory (FDI) total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in symptom severity of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in symptom severity of Suicidal Ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients showing tracer time activity curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants That Are Progression-free
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with lack of progressive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image Quality measured by resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image Quality measured by signal to noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suitability for routine use measured by imaging time and ease of use
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: percentage reduction of women with metabolic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lymphocyte reconstitution kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Validity of TMHT in prediction of difficult airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of Participants With Any Foot Blister
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge assessed on the Health-Promoting Lifestyle Profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fingolimod plasma Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fingolimod AUC0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fingolimod AUC0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of care provided by the Respiratory Nursing Service
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to discharge alive from hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Study Participants Enrolled and Treated
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: seizure frequency per 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: >75% seizure frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: EORTC-QLQ-C30 Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Milk samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity in determining malignant or benign diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of units of packed red blood cells transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Performance change in computerized attentional filter exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction change in computerized attentional filter exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance change in working memory and filtering performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction change in working memory and filtering performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of follicles greater than or equal to 15 mm on day of hCG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak serum estradiol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: stroke or death after EC-IC bypass surgery or medical therapy
Endpoint domain: Mortality/survival
Primary endpoint: volume change of Vestibular Schwannoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in rectus femoris cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Perinatal results
Endpoint domain: Mortality/survival
Primary endpoint: Sustained Virologic Response 12 (SVR-12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients taking bisphosphonate therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Baseline in Unstimulated Salivary Flow (uSFR) Rate at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant's Global Impression of Change Scale (GICS) at Week 4
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gross Motor Development at 36 Mos of Age or at Death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fine Motor Adaptive Development at 36 Mos of Age or at Death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Personal-Social Development at 36 Mos of Age or at Death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language Development at 36 Mos of Age or at Death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With TMA Event-free Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With Complete TMA Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-alcoholic fatty liver disease (NAFLD) grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Participants Achieving a 75% Reduction in the Psoriasis Area and Severity Index (PASI75) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants Achieving a Physician's Global Assessment (PGA) Response of Clear or Almost Clear at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient-oriented composite endpoint
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mortality and prolonged ICU stay
Endpoint domain: Mortality/survival
Primary endpoint: Change in Number of Unique Bacterial Isolates - Sternal Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Number of Unique Bacterial Isolates - Graft Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PICC catheter displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Physician's Global Evaluation of Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somatic Symptoms Scale (SSC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events related to skin cancer treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of high dose chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of patients discharged alive from ICU at Day 15
Endpoint domain: Mortality/survival
Primary endpoint: COPD Self-Efficacy Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COPD Assessment Test Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Anxiety Depression Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in motor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erlotinib pharmacokinetics (PK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in optimism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in control over the future
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of Analgesic Narcotic
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with occult hepatic metastasis missed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Subjects Who Tolerated a Single Highest Dose of at Least 600 mg
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-Rated TMD Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiologic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of csPCa detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Euglycemia achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abdominal aortic measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients healed from severe esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient rated wrist evaluation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants with Viral Acute Gastroenteritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: WOMAC VA 3.0 pain and physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole Brain Atrophy Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebrovascular lesions on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Liver transplant-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Morphologic and functional changes of mitral valve anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Musculoskeletal adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Serum 25 hydroxy vitamin D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total score on the Hamilton Rating Scale for depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average radiation dermatitis intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: parasympathetic tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulna length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sugar-sweetened beverage intake in kcals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in PHNO Binding Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of predicted response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proper placement of ng/og tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decision Conflict Scale (DCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Approval of prosocial motivation to blood donation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Flow-Mediated Dilatation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: dose of remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent of subjects achieving HAI seroconversion against the A/H7N9 antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mature oocyte number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of Patients Who Achieve an Undetectable PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of falls per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled CO validated abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hsCRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 12-month rate of success in preventing relapse of nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reproducibility of chest x-ray in diagnosing heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time From Transplant to Neutrophil Count Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum Plasma Concentration (C[max])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to Infinite Time (AUC [0-last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H-pylori confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain (visual analogue scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of catheters presenting any kind of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in caloric intake and hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fat tissue characteristics and body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in metabolic hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acute and dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Intra-hospital management times
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intervention efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevention efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of the combination treatment
Endpoint domain: Adverse events/effects
Primary endpoint: MRT measured from finger Photoplethysmography in response to changes in breathing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRT measured from finger Photoplethysmography in response to light source
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRT measured from finger Photoplethysmography in response to temperature changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral microbiome characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAV score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of tachyarrhythmic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidences of Second primary malignancies
Endpoint domain: Mortality/survival
Primary endpoint: number of patients with staphylococcus aureus carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: ICD Discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Histological and molecular assessment of tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Record number and type of any AE
Endpoint domain: Adverse events/effects
Primary endpoint: Net Fluid Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of ionizing radiation exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Incidence of HPV Type 31/33/45/52/58-related Disease
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titers (GMTs) to HPV Types 6/11/16/18/31/33/45/52/58
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With One or More Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Delivery Prior to 36 weeks
Endpoint domain: Mortality/survival
Primary endpoint: ED90% of Midazolam for sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elimination half life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in prostate volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to life-modifying treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Phase angle difference (DLMO - sleep midpoint)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensibility of 99mTc-PSMA Radioguided surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of relapses during 3 months after training-extinction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average annual number of new cases of diabetes
Endpoint domain: Mortality/survival
Primary endpoint: Overall Response Rate (ORR) in MDS Participants with Hypomethylating Agent Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate (ORR) in MDS Participants Who Have Not Received Hypomethylating Agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute exacerbation of COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Virological Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular Invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Early recurrence
Endpoint domain: Mortality/survival
Primary endpoint: KOOS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration for successful placement of needle into subclavian vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Global pain self-assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing